课题基金 / 基金详情

项目摘要

项目成果

JOSEPH P. SCHACHT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application proposes an investigation of a putative endophenotype and candidate genetic variant for cannabis abuse and dependence. A growing body of literature suggests that psychological reactions to the acute effects of marijuana may differ between frequent and infrequent cannabis users. The purpose of the proposed study is to build upon this body of research by investigating the relationship between frequency of marijuana use and subjective reactions to the acute effects of marijuana. A promising candidate genetic locus, the CNR1 SNP, rs2023239, will also be examined, with respect to its relationship to the endophenotype of differential subjective reaction and to its functional significance. Frequent and infrequent cannabis users will be recruited to examine: 1) whether a significant between-group difference in psychological reaction to an acute marijuana administration episode exists, such that frequent users report more positive and fewer negative psychological reactions; 2) whether the effect of the SNP on subjective reaction mediates its effect on frequency of cannabis use; and 3) what the functional significance of the CNR1 SNP is with respect to the function of the cannabinoid receptor gene. Findings will contribute to the development of an endophenotype of cannabis use-related psychopathology. As discussed in the application, problem use of marijuana presents a growing public health problem. Marijuana is the most commonly used illicit drug in the United States and most of the world, and a growing percentage of users now report difficulties in controlling their marijuana use. The proposed research will aid treatment of problem marijuana use by attempting to identify genetic and behavioral markers that make people more likely to develop cannabis abuse or dependence. Knowledge of these markers will allow health care providers to create targeted interventions to treat these disorders.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/npp.2009.200
发表时间: 2010-03
期刊: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子: --
作者: []
通讯作者:
DOI: 10.1007/s00213-008-1397-z
发表时间: 2009-04
期刊: PSYCHOPHARMACOLOGY
影响因子: 3.4
作者: [Schacht, Joseph P., Selling, Rebecca E., Hutchison, Kent E.]
通讯作者: Hutchison, Kent E.
An exploratory randomized controlled trial of the effects of oral semaglutide on alcohol craving and consumption
  • 批准号:
    10747743
  • 项目类别:
  • 资助金额:
    $42.9万
  • 财政年份:
    2023
  • 负责人:
    JOSEPH P. SCHACHT
  • 依托单位:
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder
  • 批准号:
    9918216
  • 项目类别:
  • 资助金额:
    $36.32万
  • 财政年份:
    2019
  • 负责人:
    JOSEPH P. SCHACHT
  • 依托单位:
A pharmacogenetic human laboratory investigation of brexpiprazole in Alcohol Use Disorder
  • 批准号:
    10022084
  • 项目类别:
  • 资助金额:
    $48.99万
  • 财政年份:
    2019
  • 负责人:
    JOSEPH P. SCHACHT
  • 依托单位:
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder
  • 批准号:
    10369711
  • 项目类别:
  • 资助金额:
    $36.32万
  • 财政年份:
    2019
  • 负责人:
    JOSEPH P. SCHACHT
  • 依托单位:
海外基金